Genekam has developed
ultrasensitive Magnetic beads ELISA for SARS CoV-2
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.